Furthermore, subsequent studies have established that the siRNA could efficiently inhibit PD-L1 and help to improve the response of cytotoxic T lymphocytes to tumour cells and repolarize tumour-allied macrophages from the M2 to M1 subtype states. Here, CD274 is linked to neoplasm.